PET/MRI in the Diagnosis of Chronic Pain
common.study.values.description
“PET/MRI in the Diagnosis of Chronic Pain”
Several studies have implicated involvement of sigma-1 receptors (SR1s) in the generation of chronic pain, while others are investigating anti SR1 drugs for treatment of chronic pain. Using [18F]-FTC-146 and positron emission tomography/magnetic resonance imaging (PET/MRI), the investigators hope to identify the source of pain generation in patients with chronic pain. The purpose of this study is to compare the uptake of [18F]FTC-146 in healthy volunteers to that of individuals suffering from chronic pain.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - [18F]FTC-146
Adult participants will be injected with 5-10 mCi of [18F]FTC-146 and undergo a PET/MRI scan.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Use of [18F]FTC-146 PET/MRI in the Diagnosis of Chronic Pain
common.study.values.clinical-trial-id
NCT03556137
participant.views.study.view.id
zbqwpe
